BRCA1, BRCA2, Breast cancer survival, Familial cancer syndromes, Screening,
International Journal of Cancer
Erasmus MC: University Medical Center Rotterdam

Saadatmand, S, Obdeijn, A.I.M, Rutgers, E.J.T, Oosterwijk, J.C, Tollenaar, R.A.E.M, Woldringh, G.H, … Tilanus-Linthorst, M.M.A. (2015). Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International Journal of Cancer. doi:10.1002/ijc.29534